Literature DB >> 28045459

Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.

Mireia Lopez-Siles1, Sylvia H Duncan2, L Jesús Garcia-Gil1, Margarita Martinez-Medina1.   

Abstract

There is an increasing interest in Faecalibacterium prausnitzii, one of the most abundant bacterial species found in the gut, given its potentially important role in promoting gut health. Although some studies have phenotypically characterized strains of this species, it remains a challenge to determine which factors have a key role in maintaining the abundance of this bacterium in the gut. Besides, phylogenetic analysis has shown that at least two different F. prausnitzii phylogroups can be found within this species and their distribution is different between healthy subjects and patients with gut disorders. It also remains unknown whether or not there are other phylogroups within this species, and also if other Faecalibacterium species exist. Finally, many studies have shown that F. prausnitzii abundance is reduced in different intestinal disorders. It has been proposed that F. prausnitzii monitoring may therefore serve as biomarker to assist in gut diseases diagnostics. In this mini-review, we aim to serve as an overview of F. prausnitzii phylogeny, ecophysiology and diversity. In addition, strategies to modulate the abundance of F. prausnitzii in the gut as well as its application as a biomarker for diagnostics and prognostics of gut diseases are discussed. This species may be a useful potential biomarker to assist in ulcerative colitis and Crohn's disease discrimination.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28045459      PMCID: PMC5364359          DOI: 10.1038/ismej.2016.176

Source DB:  PubMed          Journal:  ISME J        ISSN: 1751-7362            Impact factor:   10.302


  89 in total

1.  Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: a potential role for these agents in the pathogenesis of ulcerative colitis.

Authors:  S U Christl; H D Eisner; G Dusel; H Kasper; W Scheppach
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

2.  Dominant and diet-responsive groups of bacteria within the human colonic microbiota.

Authors:  Alan W Walker; Jennifer Ince; Sylvia H Duncan; Lucy M Webster; Grietje Holtrop; Xiaolei Ze; David Brown; Mark D Stares; Paul Scott; Aurore Bergerat; Petra Louis; Freda McIntosh; Alexandra M Johnstone; Gerald E Lobley; Julian Parkhill; Harry J Flint
Journal:  ISME J       Date:  2010-08-05       Impact factor: 10.302

3.  A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease.

Authors:  S Salvatore; R Heuschkel; S Tomlin; S E Davies; S Edwards; J A Walker-Smith; I French; S H Murch
Journal:  Aliment Pharmacol Ther       Date:  2000-12       Impact factor: 8.171

4.  Towards the human intestinal microbiota phylogenetic core.

Authors:  Julien Tap; Stanislas Mondot; Florence Levenez; Eric Pelletier; Christophe Caron; Jean-Pierre Furet; Edgardo Ugarte; Rafael Muñoz-Tamayo; Denis L E Paslier; Renaud Nalin; Joel Dore; Marion Leclerc
Journal:  Environ Microbiol       Date:  2009-07-06       Impact factor: 5.491

5.  Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer.

Authors:  Ramadass Balamurugan; Ethendhar Rajendiran; Sarah George; G Vijay Samuel; Balakrishnan S Ramakrishna
Journal:  J Gastroenterol Hepatol       Date:  2008-07-08       Impact factor: 4.029

Review 6.  Role of bacteria in the etiopathogenesis of inflammatory bowel disease.

Authors:  Nicolas Barnich; Arlette Darfeuille-Michaud
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

7.  Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease.

Authors:  Ben Willing; Jonas Halfvarson; Johan Dicksved; Magnus Rosenquist; Gunnar Järnerot; Lars Engstrand; Curt Tysk; Janet K Jansson
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

8.  Symbiotic gut microbes modulate human metabolic phenotypes.

Authors:  Min Li; Baohong Wang; Menghui Zhang; Mattias Rantalainen; Shengyue Wang; Haokui Zhou; Yan Zhang; Jian Shen; Xiaoyan Pang; Meiling Zhang; Hua Wei; Yu Chen; Haifeng Lu; Jian Zuo; Mingming Su; Yunping Qiu; Wei Jia; Chaoni Xiao; Leon M Smith; Shengli Yang; Elaine Holmes; Huiru Tang; Guoping Zhao; Jeremy K Nicholson; Lanjuan Li; Liping Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-05       Impact factor: 11.205

9.  Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?

Authors:  Wenjing Jia; Rebekah N Whitehead; Lesley Griffiths; Claire Dawson; Rosemary H Waring; David B Ramsden; John O Hunter; Jeffrey A Cole
Journal:  FEMS Microbiol Lett       Date:  2010-07-08       Impact factor: 2.742

10.  Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.

Authors:  Rebeca Martín; Sylvie Miquel; Florian Chain; Jane M Natividad; Jennifer Jury; Jun Lu; Harry Sokol; Vassilia Theodorou; Premysl Bercik; Elena F Verdu; Philippe Langella; Luis G Bermúdez-Humarán
Journal:  BMC Microbiol       Date:  2015-03-21       Impact factor: 3.605

View more
  144 in total

1.  Prebiotics from acorn and sago prevent high-fat-diet-induced insulin resistance via microbiome-gut-brain axis modulation.

Authors:  Shokouh Ahmadi; Ravinder Nagpal; Shaohua Wang; Jason Gagliano; Dalane W Kitzman; Sabihe Soleimanian-Zad; Mahmoud Sheikh-Zeinoddin; Russel Read; Hariom Yadav
Journal:  J Nutr Biochem       Date:  2019-01-30       Impact factor: 6.048

2.  Gut microbial composition difference between pediatric ALL survivors and siblings.

Authors:  Ronay Thomas; Wendy S W Wong; Reem Saadon; Thierry Vilboux; John Deeken; John Niederhuber; Suchitra K Hourigan; Elizabeth Yang
Journal:  Pediatr Hematol Oncol       Date:  2020-05-19       Impact factor: 1.969

Review 3.  The social network of microorganisms - how auxotrophies shape complex communities.

Authors:  Karsten Zengler; Livia S Zaramela
Journal:  Nat Rev Microbiol       Date:  2018-06       Impact factor: 60.633

Review 4.  Emulating Host-Microbiome Ecosystem of Human Gastrointestinal Tract in Vitro.

Authors:  Gun-Seok Park; Min Hee Park; Woojung Shin; Connie Zhao; Sameer Sheikh; So Jung Oh; Hyun Jung Kim
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

Review 5.  Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.

Authors:  Daniel M Chopyk; Arash Grakoui
Journal:  Gastroenterology       Date:  2020-06-20       Impact factor: 22.682

Review 6.  Host-microbial interactions in metabolic diseases: from diet to immunity.

Authors:  Ju-Hyung Lee; Joo-Hong Park
Journal:  J Microbiol       Date:  2022-05-05       Impact factor: 3.422

7.  Intestinal Microbiome and Metal Toxicity.

Authors:  Senait Assefa; Gerwald Köhler
Journal:  Curr Opin Toxicol       Date:  2019-09-30

8.  Stability of the human faecal microbiome in a cohort of adult men.

Authors:  Raaj S Mehta; Galeb S Abu-Ali; David A Drew; Jason Lloyd-Price; Ayshwarya Subramanian; Paul Lochhead; Amit D Joshi; Kerry L Ivey; Hamed Khalili; Gordon T Brown; Casey DuLong; Mingyang Song; Long H Nguyen; Himel Mallick; Eric B Rimm; Jacques Izard; Curtis Huttenhower; Andrew T Chan
Journal:  Nat Microbiol       Date:  2018-01-15       Impact factor: 17.745

Review 9.  Profile of the gut microbiota of adults with obesity: a systematic review.

Authors:  Louise Crovesy; Daniele Masterson; Eliane Lopes Rosado
Journal:  Eur J Clin Nutr       Date:  2020-03-30       Impact factor: 4.016

Review 10.  Microbial genes and pathways in inflammatory bowel disease.

Authors:  Melanie Schirmer; Ashley Garner; Hera Vlamakis; Ramnik J Xavier
Journal:  Nat Rev Microbiol       Date:  2019-08       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.